Louisiana Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on September 11, 2025

September 11, 2025

Intercept Announces Voluntary Withdrawal of OCALIVA® for Primary Biliary Cholangitis (PBC) from the US Market; US Clinical Trials Involving Obeticholic Acid Placed on Clinical Hold

GlobeNewswire

September 11, 2025

Safety Shot Launches BONK Holdings to Build Treasury in $2.5 Billion BONK Ecosystem

GlobeNewswire

September 11, 2025

SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $23.6 Million in Gross Proceeds

GlobeNewswire

September 11, 2025

Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225

GlobeNewswire

September 11, 2025

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units

GlobeNewswire

September 11, 2025

Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant

GlobeNewswire

September 11, 2025

Philips and Masimo announce innovation partnership to advance access to patient monitoring measurement technologies

GlobeNewswire

September 11, 2025

Kyowa Kirin Announces Late-Breaking Abstract Presentation at the European Academy of Dermatology and Venerology Congress

GlobeNewswire

September 11, 2025

iAnthus Expands Florida Footprint with GrowHealthy Dispensary Opening in Tamarac

GlobeNewswire

September 11, 2025

Biodesix Announces One-for-Twenty Reverse Stock Split

GlobeNewswire

September 11, 2025

Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution

GlobeNewswire

September 11, 2025

CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical

GlobeNewswire

September 11, 2025

Enlivex CEO Issues Letter to Shareholders Outlining Strategic Roadmap Following Positive Phase IIa Allocetra™ Results

GlobeNewswire

September 11, 2025

IVOS Medical Joins NIH’s C3i Program to Accelerate Commercialization of BOSS G4™ Airway Management Technology

GlobeNewswire

September 11, 2025

Prof. Ahmad AbuSalah: KFSHRC’s Sustainable Digital Innovation Ecosystem Features 30+ AI Solutions and 5 New Agents in 2025

GlobeNewswire

September 11, 2025

FOXO TECHNOLOGIES INC. ANNOUNCES ACQUISITION AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.

GlobeNewswire

September 11, 2025

Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement

GlobeNewswire

September 11, 2025

Apogee Therapeutics Announces Late-Breaker Presentation of 16-Week Data from Phase 2 APEX Trial of APG777 for Moderate-to-Severe Atopic Dermatitis at the Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress

GlobeNewswire

September 11, 2025

Maze Therapeutics Announces Positive First-in-Human Results from Phase 1 Trial of MZE782, Establishing Proof of Mechanism for a Potent, Oral SLC6A19 Inhibitor with Potential to Treat Phenylketonuria (PKU) and Chronic Kidney Disease (CKD)

GlobeNewswire

September 11, 2025

Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting

GlobeNewswire